InvestorsHub Logo
Followers 1329
Posts 250527
Boards Moderated 53
Alias Born 12/07/2009

Re: None

Friday, 11/08/2019 3:07:11 PM

Friday, November 08, 2019 3:07:11 PM

Post# of 28505
Pressure BioSciences Inc.'s CEO Mr. Schumacher “We were delighted to see PBIO’s Barocycler system featured in its pivotal position in this important new tumor processing workflow that Dr. Conrads and his colleagues have presented: the critical enabling step after LMD excision and before MS analysis. Based on results to date, we believe that the number of laboratories worldwide performing laser microdissection followed by mass spectrometric analyses will increase at a steady but significant rate, that our Barocycler system will remain a critical part of this workflow, and that the adoption of this novel new workflow should result in a measurable increase in Barocycler sales over the coming months and years.”

https://www.otcmarkets.com/stock/PBIO/news/Pressure-BioSciences-Proprietary-PCT-Platform-Fills-Pivotal-Role-for-Tumor-Analyses-in-Novel-Workflow-Presented-at-Leadi?id=241937


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBIO News